discovering markers of disease progression in patients with ms treated with natalizumab
Published 2 years ago • 71 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:53
cognitive relapses as markers of disease progression in ms
-
2:08
uncovering markers of disease progression in huntington’s disease
-
2:08
understanding disease progression in ms: challenges & opportunities
-
2:14
safely switching from natalizumab to ocrelizumab in patients with ms at risk of pml
-
8:23
repair-ms and repair-pd: tackling disease progression with gold nanocrystals
-
1:41
markers of biological aging predict disability development in ms
-
1:08
surrogate markers of disease activity in ms
-
2:27
horizon scanning in treating disease progression in ms
-
6:34
searching for signs of disease progression in the brain
-
2:43
benefits of sc natalizumab in ms
-
5:03
disease progression in multiple sclerosis
-
1:16
natalizumab concentrations during pregnancy in ms patients
-
2:12
the future of biomarkers in ms: novel discoveries and defining protocols
-
2:19
enhancing convenience and flexibility with sc natalizumab for ms
-
3:20
delaying disease progression in multiple sclerosis
-
2:18
next-ms: personalized extended interval dosing of natalizumab in rrms
-
3:33
impact of natalizumab on chronic active ms lesions
-
4:28
novel biomarkers to predict progression in ms
-
5:01
shifting toward precision care in ms using disease activity tests and serum biomarkers